NanoViricides Inc. (NNVC)

[changes_iv]

NanoViricides, Inc. has tested Flucide(TM) candidates (plural) with third party collaborators to come up with their most advanced, low toxicity, host immune system independent, effective, anti-influenza type A candidate capable of broad protection against existing and/or new strains. Can any company out there match Flucide(TM) capabilities? Can any other company come up with a therapeutic drug or vaccine that will embody all aforementioned powerful characteristics into one? The answer is NO. At this point in time only NanoViricides, Inc. can and I am certain will deliver these drugs to market. Just like the Peabody ducklings march, it will be one therapeutic drug after the other thanks to new modifications for large quantities/scale up to the facility.

"The pace of development of our broad drug pipeline is now accelerating due to the strong financing we have been able to raise concomitant with our up-listing to the NYSE-MKT exchange," said Anil R. Diwan, PhD, President.

In another news, the Company reports that the process of commissioning of its new facility in Shelton is on course. Our Bio-Analysis Group has already moved operations to the new facility. Large Scale Chemistry Group is completing the necessary modifications to the facility to enable large scale production processes. Various laboratory instruments are being installed by vendors under warranty programs for installation qualification and operational qualification.

http://www.nanoviricides.com/press%20releases/2015/NanoViricides%20Discusses%20the%20Strong%20Effectiveness%20of%20Its%20Anti-Herpes%20Drug%20Candidates%20in%20a%20Lethal%20Animal%20Model%20of%20Dermal%20Herpes%20Infection.html

What is that company drug/vaccine that directly competes with NanoViricides, Inc. FluCide(TM)? And don't go but, but, gah-gah, Yup or wow on us longs. Be specific. All companies want to have an effective broad spectrum drug. Everyone of them, without exception, want that competitive edge. At this stage of the game only one company has that edge, NanoViricides, Inc. FluCide(TM). Drugs that are independent from the immune system of the host, we only care about the virus in the host. That host could be a whale, a salamander, a mouse, or a human. NanoViricides, Inc. therapeutic drugs will only care about the offending virus in the host.

We also know, as Dr. Burke explains in his video on the Molecule-Making Machine, that it is a time consuming process to put together those LEGO-like bricks, it is laborious, and that you have to have to have the expertise to come up with the right "recipe" to build the identical characteristics LEGO-like structures in the billions, in large quantities (scale up) however, once you've develop that "recipe" you are done, you won't have to develop it again. Once you develop that scale up recipe it is in the NanoViricides, Inc. computerized library, and the next time around it is load up with bio-ink (PEG 4000, targeting ligands, etc.), execute and print.

A Molecule-Making Machine

JG36, why don't take up that one? If you need help to figure it out, get some help from Rawnoc's prime sources. What is that company with a broad-spectrum drug or vaccine that is independent from the host's immune system? Don't give us goals. We already have goals, third-party tested broad-spectrum drugs, the most advanced candidate for Influenza type A and subtypes/strains, and that candidate is FluCide(TM). Next step is scale up. Seems to me we are at a stage where we will be adding to our existing bioreactor(s) system, instruments/equipment that will make easier developing a scale up "recipe" and produce large quantities of FluCide(TM). Watch the video! Our vendor is Revolutions Medicines, Inc. or it is a vendor licensed by Revolution Medicines, Inc. or like in the case of the chip maker Intel, there is a competitor/vendor with diferent architecture like AMD. Is NanoViricides, Inc. vendor increasing their capacity to produce large quantities of FluCide? We need 2.5 kg of the FluCide(TM) candidate for BASi Tox Studies with large animals, three times the quantities that what will be required for human trials.

It was 5 to 9 years that a molecule-making machine 3d printer was just a concept that would enable fast scale up of molecules production. Two years ago it was a race to the bottom for a 3d nano printer. Today, that plug'n play equipment/instruments are here, now.

A new company, co-founded by Burke, called REVOLUTION Medicines, Inc. has already licensed the technology and is investing heavily in developing next generation molecule-making machines which will be much more powerful and easier to scale.

http://3dprint.com/50777/molecular-3d-printer/